TMO
Thermo Fisher Scientific Inc.
Income statement
| USDLine, in USD | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 47.4B | 44.6B | 42.9B | 42.9B | 44.9B | 39.2B | 32.2B | 25.5B | 24.4B | 20.9B | 18.3B | 17.0B | 16.9B | 13.1B | 12.5B | 11.6B | 10.4B | 9.9B | 10.5B | 9.7B |
Cost of revenue | — | 26.3B | 25.2B | 25.8B | 25.9B | 19.6B | 16.2B | — | — | 11.5B | 9.9B | 9.2B | 9.4B | 7.6B | 7.2B | 6.8B | 6.1B | 6.0B | 6.3B | 5.9B |
| Gross profit | — | 18.2B | 17.7B | 17.1B | 19.0B | 19.6B | 16.0B | — | — | 9.4B | 8.4B | 7.8B | 7.5B | 5.5B | 5.3B | 4.8B | 4.3B | 3.9B | 4.2B | 3.8B |
| 1.40B | 1.40B | 1.39B | 1.34B | 1.47B | 1.41B | 1.18B | 1.00B | 0.97B | 0.89B | 0.75B | 0.69B | 0.69B | 0.40B | 0.38B | 0.34B | 0.28B | — | — | — | |
| 9.19B | 8.73B | 8.60B | 8.45B | 8.99B | 8.01B | 6.93B | 6.14B | 6.06B | 5.50B | 4.97B | 4.61B | 4.90B | 3.45B | 3.35B | 3.11B | 2.73B | 2.59B | 2.69B | 2.55B | |
Other operating expenses | — | 363M | 380M | 459M | 114M | 197M | 99M | — | — | 94M | 186M | 116M | — | 78M | 82M | 97M | 60M | 303M | 285M | 281M |
| Operating income | 8.5B | 7.7B | 7.3B | 6.9B | 8.4B | 10.0B | 7.8B | 4.6B | 3.8B | 3.0B | 2.5B | 2.3B | 2.5B | 1.6B | 1.5B | 1.3B | 1.2B | 1.0B | 1.2B | 974M |
Non-operating income | −0.57B | −0.44B | −0.30B | −0.56B | −0.56B | −1.19B | −0.57B | −0.52B | −0.52B | −0.53B | −0.43B | −0.40B | −0.42B | −0.29B | −0.21B | −0.12B | −0.10B | −0.12B | — | — |
| Pretax income | 7.90B | 7.31B | 7.04B | 6.30B | 7.84B | 8.84B | 7.23B | 4.07B | 3.26B | 2.43B | 2.02B | 1.94B | 2.09B | 1.32B | 1.27B | 1.13B | 1.09B | 0.88B | — | — |
Taxes | 0.83B | 0.60B | 0.70B | 0.30B | 0.89B | 1.12B | 0.85B | 0.37B | 0.32B | 0.20B | 2.0M | −39M | 0.19B | 46M | 92M | −0.20B | 52M | 30M | — | — |
| Net income | 7.07B | 6.70B | 6.34B | 6.00B | 6.95B | 7.73B | 6.38B | 3.70B | 2.94B | 2.23B | 2.02B | 1.98B | 1.89B | 1.27B | 1.18B | 1.33B | 1.04B | 0.85B | 0.98B | 0.75B |
| Diluted EPS | 18.96 | 17.74 | 16.53 | 15.45 | 17.63 | 19.46 | 15.96 | 9.17 | 7.24 | 5.59 | 5.09 | 4.92 | 4.71 | 3.48 | 3.21 | 3.46 | 2.53 | 2.01 | 2.25 | 1.69 |
| Diluted shares | — | 378.0M | 383.0M | 388.0M | 394.0M | 397.0M | 399.0M | 403.0M | 406.0M | 398.0M | 397.0M | 402.0M | 402.3M | 365.8M | 366.6M | 384.8M | 409.4M | 422.8M | 434.7M | 443.6M |
| Revenue growth | — | +3.9% | +0.1% | −4.6% | +14.5% | +21.7% | +26.1% | +4.9% | +16.4% | +14.5% | +7.7% | +0.4% | +29.0% | +4.6% | +8.2% | +11.2% | +4.9% | −5.6% | +7.7% | — |
| Gross margin | — | 40.9% | 41.3% | 39.9% | 42.2% | 50.1% | 49.7% | — | — | 45.2% | 45.8% | 45.7% | 44.4% | 42.2% | 42.3% | 41.5% | 41.0% | 39.3% | 40.1% | 39.0% |
| Operating margin | 17.9% | 17.4% | 17.1% | 16.0% | 18.7% | 25.6% | 24.2% | 18.0% | 15.5% | 14.2% | 13.5% | 13.8% | 14.8% | 12.3% | 11.8% | 10.8% | 11.4% | 10.1% | 11.7% | 10.0% |
| Net margin | 14.9% | 15.0% | 14.8% | 14.0% | 15.5% | 19.7% | 19.8% | 14.5% | 12.1% | 10.6% | 11.1% | 11.6% | 11.2% | 9.7% | 9.4% | 11.5% | 10.0% | 8.6% | 9.3% | 7.7% |